Protecting Your Startup: Five Intellectual Property Mistakes to Avoid

​
May 20, 2026

Turning an idea into a product, and building a company to commercialise that product is not easy. Prototyping, raising funds and engaging with third party manufacturers can be complex, expensive and time-consuming. These concerns can often lead to the startup overlooking a crucial aspect for its success in the long term: Intellectual Property.

In this article, we will talk about five IP topics, focusing on patent rights, that we believe will be useful to early-stage startups to avoid making common mistakes which can damage their prospects in the medium to long term.

1. Desire to file a patent quickly at low cost without the help of a professional representative

Saving costs by asking your lead engineer to draft a patent application may be tempting, especially as using AI appears to make that task simpler and more streamlined. However, this can be a false economy. Several criteria need to be satisfied when you file an application in order to obtain a valid and worthwhile patent, and more often than not, if they have not been considered at the filing stage, they are difficult to remedy later. For example:

• adding new subject matter to a patent application can have negative repercussions on the validity of the patent application at later stages.

• using AI as your “Patent Attorney” may result in an accidental disclosure to the public. Always check how your data is used by the AI service you use before you click send. Nevertheless, AI can be a powerful tool in patent drafting and prosecution, provided that a duty of confidentiality is in place, and that the output of an AI tool is carefully reviewed by a professional. For more information, see Visser AI’s hybrid intelligence service.

• many jurisdictions are based on a first to file system (rather than first to invent). Filing a patent application quickly may reduce the likelihood of new documents being prejudicial to the patent’s validity, or accidental disclosure. However, it is desirable for a patent application to be drafted well with a commercially useful scope of protection, keeping in mind the applicable rules relating to patent validity.

• It’s important to ensure that the entity filing the application has the right to be granted a patent. In practice, this means ensuring that title to the rights in the invention has passed from the inventor to the startup; fixing this later can be expensive and difficult, especially if the inventor has disappeared or is no longer friendly. And difficulties in showing you own the rights may affect your ability to attract funding.

2. Public disclosures

Disclosing an invention without having confidentiality obligations in place (like at a conference) can affect the validity of your patent application. In the UK and elsewhere, this can result in the patent rights being lost. Before disclosing your invention, even to a close friend:

• ensure the recipient is under a duty of confidentiality and, if not, set up a confidentiality agreement; or

• file a patent application.

However,  all hope is not lost if something is accidentally disclosed. For example, you may still be able to get patent protection in the US by using the 12-months’ grace period from the date of first disclosure by the inventor.

Also keep in mind that most jurisdictions have provisions to protect rights if public disclosure was made in breach of confidence. For example, a disgruntled ex-employee may disclose details relating to an invention before a patent application is filed. In that case, it may still be possible to file a patent application without the disclosure being prejudicial to validity provided it is filed within a certain amount of time from the date of the disclosure (typically 6 months).

3. Failing to set up enforceable contracts with third parties

Relying on a manufacturer overseas may be a viable solution for reducing the cost of getting your product to market. However, working with third parties often come with risks: for example, a manufacturer may start making your product and selling it in another country, becoming a competitor.

• Make sure you have a contract with the manufacturer which can be enforced in the manufacturer’s own country. You may win an action before a Court in your own country, but find it is not useful to prevent further misuse of your IP.

• Set out IP ownership clauses, clear terms of use, and enforceable penalties for breach of contract.

Similar arguments apply to research collaborations with third parties. For example, it is important to establish what is background and foreground IP well in advance of the start of a research collaboration; otherwise, the ownership of the research IP may be difficult to settle.

4. Clarity in how to use a patent

A patent can be a valuable tool to prevent others from working the patented invention, but it does not give you the right to work the invention: it is only a right to stop other people from using the invention.

Owning patents can increase the value of your company, particularly in the eyes of an investor.

This can be advantageous during early-stage funding, since you may be able to raise more money, or retain a larger slice of your company.

Remember this applies for other forms of registered intellectual properties as well, such as registered designs and trademarks.

5. Having an IP strategy

Products change from iteration to iteration. Having a patent with a broad scope of protection is often desirable, but an excessive breadth of the patent’s claims may render the patent invalid from the perspective of novelty and/or inventiveness. On the other hand, a patent that is too narrow may have limited commercial use, as it may be easy for a competitor to design around the patent, or it may be difficult to assert the patent during an infringement action.

Even if you have a broad enough valid patent that is still relevant throughout the different iterations of your product, you may want to consider drafting an IP strategy, and conducting regular patent portfolio reviews in order to:

• file more patent applications (or register designs) as the product evolves to cover new features – having multiple patents directed to different key aspects of a product may help in asserting your rights at a more granular level;

• consider licensing IP: if you are not using the patent yourself, this may be a valuable source of income; and

• abandon obsolete patents to save money on renewal fees.

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
Quantum IP Strategy: Own control Points, Not Patent Counts
14 October 2026
In quantum, the strongest portfolios will not be the biggest. Stuart Malcolm sets out six moves for owning the control points the market cannot route around, and the questions investors will ask.
#
Consulting
​
Targeted, Not Transformative: The UKIPO’s Considered Course on SEPs
13 October 2026
Andrew Sharples analyses the UKIPO's response to its SEP consultation, exploring proposed changes to FRAND dispute resolution, SEP transparency and licensing guidance, and what they mean for SEP holders and implementers.
#
Consulting
​
Chinese Companies in European Patent Litigation
30 September 2026
Chinese companies are becoming increasingly active in European patent litigation, both as defendants and as patent owners enforcing their own rights. This article examines the growing role of Europe and the Unified Patent Court (UPC) in global patent disputes, highlighting key cases involving Chinese businesses and the strategic opportunities and risks that come with operating in European markets. It is the first in a series exploring the practical implications of European patent enforcement for Chinese companies.
#
Patenting
​
How to mitigate prior art traps for follow-on pharma patents
27 August 2026
Follow-on patents are increasingly important for pharmaceutical innovators. Learn how new EMA clinical trial disclosure rules create prior art risks and discover practical strategies to protect pharmaceutical IP and maximise patent value.
#
Consulting
​
Chinese companies and the UPC: from enforcement targets to strategic users
13 August 2026
Chinese companies are playing an increasingly significant role in UPC litigation, accounting for around 38% of infringement actions in 2025. While many remain defendants, a growing number are actively using the Unified Patent Court to enforce their own patent rights across Europe. The trend highlights the UPC's rising importance for Chinese businesses operating in sectors such as telecommunications, semiconductors, medical devices and renewable energy, and signals a shift in global patent enforcement strategy.
#
Patenting
​
Evaluating the environmental impact of patent AI.
31 July 2026
AI's environmental impact is rarely out of the headlines, but how does it compare to the benefits it delivers in practice? In this article, Laurence Brown examines the energy use of AI-assisted patent drafting, comparing it with traditional drafting workflows. While measuring AI's true environmental footprint is far from straightforward, the analysis suggests that AI-assisted patent drafting may already be more energy efficient, while delivering significant productivity gains for patent professionals.
#
Patenting
​
UPC appeals after three years: Early indications on appeal success rates
15 July 2026
Three years into the UPC, appeal overturn rates sit at 56% for both substantive and preliminary injunction cases, with Kodak v Fujifilm among the rulings reshaping outcomes on appeal.
#
Litigation
​
The UPC After Three Years: From Experiment to Enforcement Forum
15 July 2026
1,282 cases filed at the UPC in three years: infringement actions have surged while revocation filings stayed flat, easing fears the Court would become a European patent graveyard.
#
Litigation
​
Podcast: Building an AI-Native Law Firm
26 June 2026
On the Technically Legal podcast, EIP partner Laurence Brown discusses how Visser AI is redesigning patent workflows, letting the firm offer fixed fees without trading away speed or quality.
#
Patenting
​
Choosing your SEP battleground: UPC, Germany or UK?
07 June 2026
Choosing the right venue for SEP litigation can significantly influence the outcome of FRAND disputes. This article compares the UPC, German and UK courts, examining their approaches to injunctions, FRAND defences, rate-setting and enforcement. It highlights the strategic advantages of each jurisdiction and explains why many SEP owners are increasingly turning to the UK and UPC as part of their European enforcement strategy.
#
Litigation
​
Synthetic Lethality & AI: IP Strategy in Oncology
26 May 2026
This article explores the resurgence of synthetic lethality in precision oncology, highlighting how AI and machine learning are accelerating the discovery of new therapeutic targets. It also examines growing clinical activity, investment, and the evolving intellectual property challenges shaping this emerging field.
#
Consulting
​
Inside the Visser AI Launch Party
20 May 2026
EIP has officially launched Visser AI®, our hybrid intelligence service for patent drafting and prosecution. Watch the launch film from our event at The Boundary in Shoreditch, and discover how our team of European and US patent attorneys — working with the Patently AI platform , delivers faster, lower-cost work at the EPO, USPTO and beyond.
#
Consulting
​
Protecting Your Startup: Five Intellectual Property Mistakes to Avoid
20 May 2026
Early‑stage startups often focus on product development and fundraising, but overlooking intellectual property (IP) can seriously damage long‑term value. This article explores five common IP mistakes startups make, with a particular focus on patents. It covers the risks of filing patents without professional advice, making public disclosures too early, failing to put enforceable contracts in place with third parties, misunderstanding what patent rights actually provide, and neglecting to develop a clear IP strategy. By highlighting these pitfalls and offering practical guidance, the article helps startups protect their innovations, strengthen their commercial position, and improve their prospects with investors.
#
Consulting
​
Technology, Patents, and Sport
13 May 2026
VAR, goal-line tech, AI 3D player avatars, wearable trackers, the technology reshaping the 2026 World Cup and elite sport rests on a patent system that makes the R&D investment behind it worth taking.
#
Patenting
​
Patents or Trade Secrets? When to Patent in Deep Tech Innovation
11 May 2026
Deep tech companies face unique IP challenges due to long development cycles, high upfront investment, and complex technologies that combine products and processes. This article explores when patents, trade secrets, or a combination of both offer the strongest protection. It explains how factors such as detectability, reverse engineering risk, disclosure to third parties, and employee mobility should shape IP strategy decisions. While patents are often best suited to externally visible or licensable technologies, trade secrets can be highly effective for internal processes and know‑how that deliver performance or cost advantages.
#
Patenting
​